Back to Results
First PageMeta Content
Anatomy / Immunosuppressants / Monoclonal antibodies / Abdominal pain / Arthritis / Infliximab / Adalimumab / Ulcerative colitis / Ankylosing spondylitis / Medicine / Health / Autoimmune diseases


July 2014 PBAC OUTCOMES - "Subsequent" Decisions not to Recommend Drug Name, form(s), strength(s), Sponsor, Type of submission TGA Indication Current PBS Listing
Add to Reading List

Document Date: 2015-01-19 17:21:09


Open Document

File Size: 33,39 KB

Share Result on Facebook

Company

Leo Pharma Pty Ltd / AbbVie Pty Ltd / Novartis Vaccines and Diagnostics Pty Ltd / PBAC / /

Country

Australia / /

Event

Product Recall / Product Issues / FDA Phase / /

IndustryTerm

prevention of meningococcal B disease / meningitidis / /

MedicalCondition

B infection / keratoses / iron deficiency / solar keratoses / overall disease / disease / active ankylosing spondylitis / invasive disease / nasopharyngitis / gastroenteritis / solar keratosis / fever / severe active rheumatoid arthritis / severe refractory Crohn disease / ulcerative colitis / severe chronic plaque psoriasis / B disease / infection / severely active ulcerative colitis / severe active psoriatic arthritis / severe ulcerative colitis / dynamic infectious disease / /

MedicalTreatment

vaccination / cryotherapy / /

Organization

IMD / /

Position

Governor / /

Product

Humira / previous trial data / FU / SK / /

ProvinceOrState

Saskatchewan / /

Technology

antibodies / /

URL

www.pbs.gov.au / /

SocialTag